Erin Wright
Stock Analyst at Morgan Stanley
(1.51)
# 3,168
Out of 4,829 analysts
217
Total ratings
100%
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by Erin Wright
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BTSG BrightSpring Health Services | Maintains: Overweight | $20 → $25 | $22.82 | +9.58% | 3 | May 9, 2025 | |
| PAHC Phibro Animal Health | Maintains: Equal-Weight | $20 → $21 | $22.47 | -6.54% | 22 | May 8, 2025 | |
| IDXX IDEXX Laboratories | Maintains: Overweight | $548 → $558 | $491.70 | +13.48% | 13 | May 5, 2025 | |
| CI The Cigna Group | Maintains: Overweight | $379 → $390 | $333.46 | +16.96% | 5 | May 5, 2025 | |
| CAH Cardinal Health | Maintains: Overweight | $142 → $166 | $148.22 | +12.00% | 10 | May 5, 2025 | |
| PETS PetMed Express | Maintains: Underweight | $3.5 → $3.2 | $3.62 | -11.60% | 12 | Apr 17, 2025 | |
| MCK McKesson | Maintains: Overweight | $642 → $745 | $693.46 | +7.43% | 6 | Apr 2, 2025 | |
| NVST Envista Holdings | Maintains: Equal-Weight | $20 → $19 | $17.59 | +8.02% | 8 | Mar 6, 2025 | |
| ELAN Elanco Animal Health | Maintains: Equal-Weight | $14 → $13 | $11.96 | +8.70% | 11 | Feb 26, 2025 | |
| ZTS Zoetis | Maintains: Overweight | $243 → $238 | $159.27 | +49.43% | 7 | Feb 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $301 → $285 | $249.53 | +14.21% | 3 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $280 → $272 | $181.88 | +49.55% | 21 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $23 | $15.82 | +45.39% | 12 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $145 → $172 | $176.96 | -2.80% | 5 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $643 → $551 | $404.58 | +36.19% | 2 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $9 → $7 | $11.22 | -37.61% | 7 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $69 → $65 | $68.64 | -5.30% | 4 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $110 → $100 | $66.97 | +49.32% | 4 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $587 | $380.64 | +54.21% | 3 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Overweight | $300 | $245.73 | +22.09% | 4 | Aug 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $39 → $42 | $12.02 | +249.42% | 5 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $282 → $288 | $189.73 | +51.79% | 6 | Jun 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $342 → $352 | $138.79 | +153.62% | 4 | May 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $42 → $44 | $1.99 | +2,116.62% | 2 | May 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $178 → $181 | $299.21 | -39.51% | 8 | Mar 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $17 | $81.74 | -79.20% | 6 | Feb 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $104 → $121 | $39.57 | +205.79% | 7 | Jan 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $556 → $580 | $403.13 | +43.87% | 4 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $35 | $11.98 | +192.15% | 1 | Jan 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $181 → $205 | $133.96 | +53.03% | 2 | Jul 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $11 | $19.70 | -44.16% | 6 | May 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $175 → $157 | $148.99 | +5.38% | 1 | Apr 2, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $42 → $38 | $23.07 | +64.72% | 1 | May 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $31 → $17 | $7.01 | +142.51% | 1 | Nov 20, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $300 → $308 | $473.52 | -34.96% | 1 | Oct 25, 2017 |
BrightSpring Health Services
May 9, 2025
Maintains: Overweight
Price Target: $20 → $25
Current: $22.82
Upside: +9.58%
Phibro Animal Health
May 8, 2025
Maintains: Equal-Weight
Price Target: $20 → $21
Current: $22.47
Upside: -6.54%
IDEXX Laboratories
May 5, 2025
Maintains: Overweight
Price Target: $548 → $558
Current: $491.70
Upside: +13.48%
The Cigna Group
May 5, 2025
Maintains: Overweight
Price Target: $379 → $390
Current: $333.46
Upside: +16.96%
Cardinal Health
May 5, 2025
Maintains: Overweight
Price Target: $142 → $166
Current: $148.22
Upside: +12.00%
PetMed Express
Apr 17, 2025
Maintains: Underweight
Price Target: $3.5 → $3.2
Current: $3.62
Upside: -11.60%
McKesson
Apr 2, 2025
Maintains: Overweight
Price Target: $642 → $745
Current: $693.46
Upside: +7.43%
Envista Holdings
Mar 6, 2025
Maintains: Equal-Weight
Price Target: $20 → $19
Current: $17.59
Upside: +8.02%
Elanco Animal Health
Feb 26, 2025
Maintains: Equal-Weight
Price Target: $14 → $13
Current: $11.96
Upside: +8.70%
Zoetis
Feb 14, 2025
Maintains: Overweight
Price Target: $243 → $238
Current: $159.27
Upside: +49.43%
Feb 12, 2025
Maintains: Equal-Weight
Price Target: $301 → $285
Current: $249.53
Upside: +14.21%
Feb 6, 2025
Maintains: Overweight
Price Target: $280 → $272
Current: $181.88
Upside: +49.55%
Dec 17, 2024
Maintains: Overweight
Price Target: $30 → $23
Current: $15.82
Upside: +45.39%
Dec 17, 2024
Upgrades: Overweight
Price Target: $145 → $172
Current: $176.96
Upside: -2.80%
Oct 23, 2024
Maintains: Overweight
Price Target: $643 → $551
Current: $404.58
Upside: +36.19%
Oct 11, 2024
Maintains: Underweight
Price Target: $9 → $7
Current: $11.22
Upside: -37.61%
Nov 14, 2023
Maintains: Underweight
Price Target: $69 → $65
Current: $68.64
Upside: -5.30%
Nov 2, 2023
Maintains: Overweight
Price Target: $110 → $100
Current: $66.97
Upside: +49.32%
Jul 14, 2023
Reiterates: Overweight
Price Target: $587
Current: $380.64
Upside: +54.21%
Aug 22, 2022
Assumes: Overweight
Price Target: $300
Current: $245.73
Upside: +22.09%
Jul 30, 2021
Maintains: Outperform
Price Target: $39 → $42
Current: $12.02
Upside: +249.42%
Jun 18, 2021
Maintains: Outperform
Price Target: $282 → $288
Current: $189.73
Upside: +51.79%
May 28, 2021
Maintains: Neutral
Price Target: $342 → $352
Current: $138.79
Upside: +153.62%
May 11, 2021
Maintains: Outperform
Price Target: $42 → $44
Current: $1.99
Upside: +2,116.62%
Mar 17, 2021
Maintains: Outperform
Price Target: $178 → $181
Current: $299.21
Upside: -39.51%
Feb 26, 2021
Maintains: Neutral
Price Target: $14 → $17
Current: $81.74
Upside: -79.20%
Jan 13, 2021
Maintains: Outperform
Price Target: $104 → $121
Current: $39.57
Upside: +205.79%
Jan 12, 2021
Maintains: Outperform
Price Target: $556 → $580
Current: $403.13
Upside: +43.87%
Jan 5, 2021
Initiates: Neutral
Price Target: $35
Current: $11.98
Upside: +192.15%
Jul 23, 2020
Maintains: Outperform
Price Target: $181 → $205
Current: $133.96
Upside: +53.03%
May 5, 2020
Maintains: Neutral
Price Target: $12 → $11
Current: $19.70
Upside: -44.16%
Apr 2, 2020
Maintains: Outperform
Price Target: $175 → $157
Current: $148.99
Upside: +5.38%
May 9, 2018
Maintains: Outperform
Price Target: $42 → $38
Current: $23.07
Upside: +64.72%
Nov 20, 2017
Maintains: Underperform
Price Target: $31 → $17
Current: $7.01
Upside: +142.51%
Oct 25, 2017
Maintains: Neutral
Price Target: $300 → $308
Current: $473.52
Upside: -34.96%